Overview of the 2022 WHO classification of neuroendocrine neoplasms
In this review, we detail the changes and the relevant features that are applied to
neuroendocrine neoplasms (NENs) in the 2022 WHO Classification of Endocrine and …
neuroendocrine neoplasms (NENs) in the 2022 WHO Classification of Endocrine and …
[HTML][HTML] Lung neuroendocrine neoplasms: recent progress and persistent challenges
N Rekhtman - Modern Pathology, 2022 - Elsevier
This review summarizes key recent developments relevant to the pathologic diagnosis of
lung neuroendocrine neoplasms, including carcinoids, small cell lung carcinoma (SCLC) …
lung neuroendocrine neoplasms, including carcinoids, small cell lung carcinoma (SCLC) …
[HTML][HTML] INSM1, a novel biomarker for detection of neuroendocrine neoplasms: cytopathologists' view
Z Maleki, A Nadella, M Nadella, G Patel, S Patel… - Diagnostics, 2021 - mdpi.com
Background: Insulinoma-associated protein 1 (INSM1) has been considered as a novel
immunostain for neuroendocrine tumors (NETs) and is hypothesized to be more reliable …
immunostain for neuroendocrine tumors (NETs) and is hypothesized to be more reliable …
The complex histopathological and immunohistochemical spectrum of neuroendocrine tumors—an overview of the latest classifications
AA Gheorghișan-Gălățeanu, A Ilieșiu… - International Journal of …, 2023 - mdpi.com
Neuroendocrine neoplasms (NENs) originate from the neuroendocrine cell system, which
may either take the shape of organoid cell aggregations or be composed of dispersed cells …
may either take the shape of organoid cell aggregations or be composed of dispersed cells …
Insulinoma-associated-1 (INSM1) expression in thymic squamous cell carcinoma
J Kashima, T Hashimoto, A Yoshida, Y Goto, T Ushiku… - Virchows Archiv, 2022 - Springer
Thymic squamous cell carcinoma (TSC) presents distinct immunohistochemical features
with its expression of CD5 and CD117, both of which are rarely expressed in squamous cell …
with its expression of CD5 and CD117, both of which are rarely expressed in squamous cell …
[HTML][HTML] Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non …
K Möller, R Uhlig, N Gorbokon, D Dum, A Menz… - Molecular and Cellular …, 2024 - Elsevier
INSM1 is a transcription factor protein which is increasingly used as an
immunohistochemical marker for neuroendocrine differentiation. To determine the …
immunohistochemical marker for neuroendocrine differentiation. To determine the …
From the ashes of “Ewing-like” sarcoma: A contemporary update of the classification, immunohistochemistry, and molecular genetics of round cell sarcomas
ME Kallen, JL Hornick - Seminars in Diagnostic Pathology, 2022 - Elsevier
Round cell sarcomas include a diverse group of bone and soft tissue tumors, which
comprise well-defined entities as well as several nascent categories presented in the 2020 …
comprise well-defined entities as well as several nascent categories presented in the 2020 …
Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor‐1 and neuroendocrine markers
Aims Nuclear protein in testis (NUT) carcinoma, an aggressive tumour driven by NUTM1
rearrangements, often involves the lung/mediastinum and shows squamous differentiation …
rearrangements, often involves the lung/mediastinum and shows squamous differentiation …
INSM1 is less sensitive but more specific than synaptophysin in gynecologic high-grade neuroendocrine carcinomas: an immunohistochemical study of 75 cases with …
Q Zou, L Zhang, Z Cheng, X Guo… - The American Journal of …, 2021 - journals.lww.com
Abstract Insulinoma-associated protein 1 (INSM1) has emerged as a promising diagnostic
marker for high-grade neuroendocrine carcinomas (HGNECs); however, it is controversial …
marker for high-grade neuroendocrine carcinomas (HGNECs); however, it is controversial …
Treatment-related neuroendocrine prostate carcinoma—diagnostic and molecular correlates
A Gopalan - Advances in Anatomic Pathology, 2024 - journals.lww.com
Abstract Treatment-related neuroendocrine prostate cancer is a distinctive category of
prostate cancer that arises after intensive suppression of the androgen receptor by next …
prostate cancer that arises after intensive suppression of the androgen receptor by next …